These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 27645111)

  • 61. Statin Intolerance From a Clinician's Perspective.
    Whayne TF
    Angiology; 2016 Mar; 67(3):205-7. PubMed ID: 26019266
    [No Abstract]   [Full Text] [Related]  

  • 62. [New guidelines on treatment of blood cholesterol: too much of a good thing?].
    Lippi G; Mattiuzzi C
    Recenti Prog Med; 2014 Sep; 105(9):317-21. PubMed ID: 25229759
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Statins and the neuromuscular system: a neurologist's perspective.
    Argov Z
    Eur J Neurol; 2015 Jan; 22(1):31-6. PubMed ID: 25495398
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Ezetimibe in clinical practice: from laboratory investigations to the IMPROVE-IT trial results].
    Borghi C; Filardi PP
    G Ital Cardiol (Rome); 2015; 16(7-8 Suppl 1):3S-14S. PubMed ID: 26442834
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Approach to Patients with Statin Intolerance: Evidence-Based Review].
    Almeida JT; Esteves AL; Martins F; Palma I
    Acta Med Port; 2020 Jan; 33(1):49-57. PubMed ID: 31928603
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Muscle problems due to statins: underestimated].
    Janssen SP; Smulders YM; Gerdes VE; Visseren FL
    Ned Tijdschr Geneeskd; 2010; 154():A1684. PubMed ID: 21435278
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Statin-associated muscle symptoms: position paper from the Luso-Latin American Consortium.
    Sposito AC; Faria Neto JR; Carvalho LS; Lorenzatti A; Cafferata A; Elikir G; Esteban E; Morales Villegas EC; Bodanese LC; Alonso R; Ruiz AJ; Rocha VZ; Faludi AA; Xavier HT; Coelho OR; Assad MH; Izar MC; Santos RD; Fonseca FA; Mello E Silva A; Silva PM; Bertolami MC;
    Curr Med Res Opin; 2017 Feb; 33(2):239-251. PubMed ID: 27776432
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Alirocumab: A Review in Hypercholesterolemia.
    Greig SL; Deeks ED
    Am J Cardiovasc Drugs; 2016 Apr; 16(2):141-52. PubMed ID: 26935836
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Nutraceuticals in the management of patients with statin-associated muscle symptoms, with a note on real-world experience.
    Ward NC; Pang J; Ryan JDM; Watts GF
    Clin Cardiol; 2018 Jan; 41(1):159-165. PubMed ID: 29363784
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Symptomatic myositis-myalgia in hypercholesterolemic statin-treated patients with concurrent vitamin D deficiency leading to statin intolerance may reflect a reversible interaction between vitamin D deficiency and statins on skeletal muscle.
    Glueck CJ; Abuchaibe C; Wang P
    Med Hypotheses; 2011 Oct; 77(4):658-61. PubMed ID: 21802861
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Results of a safety initiative for patients on concomitant amiodarone and simvastatin therapy in a Veterans Affairs medical center.
    Karimi S; Hough A; Beckey C; Parra D
    J Manag Care Pharm; 2010 Sep; 16(7):472-81. PubMed ID: 20726676
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Statin and cardiovascular diseases after 75 years].
    Retornaz F; Beliard S; Gremeaux E; Chiche L; Lagarde L; Andrianasolo M; Molines C; Oliver C
    Rev Med Interne; 2016 Sep; 37(9):625-31. PubMed ID: 27389014
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Evidence-based guidelines for cardiovascular risk reduction: the safety and efficacy of high-dose statin therapy.
    Ashen MD; Foody JM
    J Cardiovasc Nurs; 2009; 24(6):429-38. PubMed ID: 19786883
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Statin intolerance and statin-associated muscular pain].
    Stürzebecher PE; Schumann F; Kassner U; Laufs U
    Herz; 2022 Jun; 47(3):204-211. PubMed ID: 35451596
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Statins: The Good, the Bad, and the Unexpected.
    Mager DR
    Home Healthc Now; 2016; 34(7):388-93. PubMed ID: 27348033
    [TBL] [Abstract][Full Text] [Related]  

  • 76. An assessment by the Statin Intolerance Panel: 2014 update.
    Guyton JR; Bays HE; Grundy SM; Jacobson TA; The National Lipid Association Statin Intolerance Panel
    J Clin Lipidol; 2014; 8(3 Suppl):S72-81. PubMed ID: 24793444
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Statin myopathy--rarity or reality?].
    Pella D
    Vnitr Lek; 2010 Sep; 56(9 Suppl):972-6. PubMed ID: 21137170
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Statin Intolerance: the Clinician's Perspective.
    Stulc T; Ceška R; Gotto AM
    Curr Atheroscler Rep; 2015 Dec; 17(12):69. PubMed ID: 26490078
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Statin Intolerance: Some Practical Hints.
    Banach M; Mikhailidis DP
    Cardiol Clin; 2018 May; 36(2):225-231. PubMed ID: 29609752
    [TBL] [Abstract][Full Text] [Related]  

  • 80. 'Muscle-sparing' statins: preclinical profiles and future clinical use.
    Pfefferkorn JA
    Curr Opin Investig Drugs; 2009 Mar; 10(3):245-52. PubMed ID: 19333882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.